Geftinat 250 mg

Category:

Geftinat 250 mg (Gefitinib)Tablet is using in the therapy of non-small cell lung cancer. It is using in patients in which it has grown to other parts of the body, who have irregular epidermal growth factor receptor (EGFR) genes, and who have not had past cancer treatment.

  • Category : Anti Cancer
  • Manufacturer : Generic
  • Active Substance : Gefitinib
  • Customer Rate
  • Prescription : Required or Will Provide upon Online Doctor Consultation

INTRODUCTION

GEFTINAT 250MG TABLET contains Gefitinib which belongs to the group of medicines called Antineoplastics. It is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who have activating mutation of the EGFR-TK.

It is generally characterized by symptoms such as chest pain or discomfort, persistent cough, trouble breathing, wheezing, tiredness and difficulty while swallowing which may be diagnosed as any of its type as adenocarcinoma (cancer involving the outer part of the lung), squamous cell carcinoma (cancer occurring in the centre part of the lungs), and large cell carcinoma (cancer that can occur in any part of the lung).

Along with this treatment, your doctor might ask you to take liver function test to assess your liver function.

GEFTINAT 250MG TABLET is not recommended for use in patients allergic to Gefitinib. Before taking GEFTINAT 250MG TABLET, inform your doctor if you have other lung problems, liver, or kidney problems.

GEFTINAT 250MG TABLET is not recommended for use in pregnant and breastfeeding women. It is not recommended for use in children and adolescents (below 18 years). Consult your doctor before taking GEFTINAT 250MG TABLET.

The most common side effects of taking GEFTINAT 250MG TABLET are diarrhoea, vomiting, nausea, skin reactions, loss of appetite, weakness, and red or sore mouth. Consult with your doctor if any of the symptoms worsen.

USES OF GEFTINAT 250MG TABLET

  • Used to treat adults with non-small cell lung cancer

HOW GEFTINAT 250MG TABLET WORKS

GEFTINAT 250MG TABLET works by decreasing the survival rate and proliferation of malignant cancer cells in lung tissues by blocking a protein called epidermal growth factor receptor (EGFR) which is responsible for the growth and spread of cancer cell thereby preventing the growth and spread of cancer cells to other parts of the body.

DIRECTIONS FOR USE

Take GEFTINAT 250MG TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of GEFTINAT 250MG TABLET for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF GEFTINAT 250MG TABLET

COMMON

  • Diarrhoea
  • Vomiting
  • Nausea
  • Skin reactions (acne-like rash)
  • Loss of appetite
  • Weakness
  • Red or sore and dry mouth
  • Dry, red, or itchy eyes
  • Red and sore eyelids
  • Nail problems
  • Hair loss
  • Fever
  • Bleeding such as nosebleed or blood in urine
  • Signs of cystitis such as burning sensations while urinating, urgent need to urinate

UNCOMMON

  • Signs of inflamed pancreas such as very severe pain in the upper part of the abdomen, severe nausea and vomiting
  • Signs of inflammation of the liver such as general feeling of being unwell, with or without possible jaundice (yellowing of the skin and eyes).
  • Signs of gastrointestinal perforation such as severe stomach pain, chills, fever
  • Signs of palmar-plantar erythrodysaesthesia syndrome or hand and foot syndrome such as skin reaction on the palms of the hands and soles of the feet with tingling, numbness, swelling, redness, or pain

RARE

  • Signs of inflammation of the blood vessels in the skin such as bruising or patches of non-blanching rash on the skin
  • Signs of haemorrhagic cystitis (inflammatory condition of urinary bladder) such as burning sensation while urinating, urgent need to urinate along with blood in the urine

Stop taking GEFTINAT 250MG TABLET and contact your doctor immediately if you experience any of the following side effects:

  • Signs of allergic reaction such as swollen face, lips, tongue or throat, red and itchy skin, nettle rash and difficulty breathing and difficulty in swallowing
  • Signs of interstitial lung disease (inflammation and scarring of lung disease) such as serious breathlessness, or sudden worsening of breathlessness possibly with a cough or fever
  • Dehydration due to long term or severe diarrhoea, vomiting, nausea, or loss of appetite
  • Signs of an ulcer on the surface of the eye (cornea) such as pain, redness, watery eyes, light sensitivity, changes in vision or ingrowing eyelashes

HOW TO MANAGE SIDE EFFECTS

Nausea or Vomiting:

Stick to simple meals. Avoid eating oily, fried, and spicy foods. Do not perform any strenuous activities immediately after eating. Consult your doctor if the symptom did not improve.

Constipation:

Eat plenty of fiber rich foods such as vegetables, fresh fruits, and cereals and drink plenty of water while taking GEFTINAT 250MG TABLET. Exercise more regularly. Consult your doctor if the symptom did not improve.

Diarrhea:

Drink a lot of fluids, such as water, squash, or fruit juice to keep yourself hydrated. Do not take any medicine on your own for treating diarrhea without consulting your doctor.

Reviews

There are no reviews yet.

Be the first to review “Geftinat 250 mg”

Your email address will not be published. Required fields are marked *

Geftinat 250 mg (Gefitinib)Tablet is using in the therapy of non-small cell lung cancer. It is using in patients in which it has grown to other parts of the body, who have irregular epidermal growth factor receptor (EGFR) genes, and who have not had past cancer treatment.

    Enquiry

    Reviews

    There are no reviews yet.

    Be the first to review “Geftinat 250 mg”

    Your email address will not be published. Required fields are marked *